ArTS Archivio della ricerca di Trieste

SOBHANI, NAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.327
EU - Europa 2.194
AS - Asia 1.765
SA - Sud America 208
AF - Africa 53
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.558
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.283
PL - Polonia 850
SG - Singapore 659
CN - Cina 440
IT - Italia 406
SE - Svezia 207
HK - Hong Kong 183
VN - Vietnam 160
BR - Brasile 159
DE - Germania 140
KR - Corea 93
IE - Irlanda 90
FR - Francia 82
GB - Regno Unito 80
RU - Federazione Russa 71
FI - Finlandia 61
NL - Olanda 61
IN - India 49
UA - Ucraina 31
TR - Turchia 28
BG - Bulgaria 25
CA - Canada 24
MA - Marocco 22
AR - Argentina 21
MY - Malesia 18
JP - Giappone 16
BD - Bangladesh 14
AT - Austria 13
ES - Italia 13
MX - Messico 13
PK - Pakistan 13
BE - Belgio 12
ZA - Sudafrica 12
IQ - Iraq 11
IR - Iran 11
ID - Indonesia 10
SA - Arabia Saudita 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
JO - Giordania 7
RO - Romania 7
UZ - Uzbekistan 7
DZ - Algeria 6
EC - Ecuador 6
PH - Filippine 6
VE - Venezuela 6
MD - Moldavia 5
NZ - Nuova Zelanda 5
CL - Cile 4
IL - Israele 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
AU - Australia 3
CO - Colombia 3
KE - Kenya 3
LT - Lituania 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PS - Palestinian Territory 2
SI - Slovenia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.558
Salva come PNG Salva come JPEG
Città #
Warsaw 817
Singapore 406
Ashburn 378
Fairfield 354
Chandler 214
Houston 200
Hong Kong 177
Woodbridge 173
San Jose 163
Seattle 139
Trieste 130
Ann Arbor 118
Cambridge 115
Wilmington 107
Beijing 100
Menlo Park 88
Seoul 86
Hefei 80
Santa Clara 76
Boardman 63
Dallas 61
Columbus 59
Princeton 49
Los Angeles 45
Ho Chi Minh City 44
Chicago 43
Council Bluffs 40
Helsinki 39
Lauterbourg 39
Jacksonville 38
Munich 35
Moscow 32
Frankfurt am Main 31
Dublin 30
Milan 28
New York 26
The Dalles 26
Hanoi 25
Zgierz 25
Sofia 24
Dearborn 22
Dong Ket 22
London 19
Orem 19
Redwood City 19
Buffalo 18
Izmir 18
Bremen 17
São Paulo 17
San Diego 16
Phoenix 15
Poplar 15
Casablanca 14
Duino-Aurisina 14
Denver 13
Nuremberg 12
Shanghai 12
Tokyo 12
Montegaldella 11
Brussels 10
Hangzhou 10
Tianjin 10
Turku 10
Amsterdam 9
Atlanta 9
Boston 9
Da Nang 9
Lappeenranta 9
Chennai 8
Guangzhou 8
Johannesburg 8
Mumbai 8
Nanjing 8
Redondo Beach 8
Rome 8
Toronto 8
Udine 8
Amman 7
Decatur 7
Eagan 7
Redmond 7
Tehran 7
Düsseldorf 6
Florence 6
Genoa 6
Kunming 6
Montreal 6
Norwalk 6
Rio de Janeiro 6
Tashkent 6
Vienna 6
Belo Horizonte 5
Brooklyn 5
Changsha 5
Chisinau 5
Dongguan 5
Fuzhou 5
Lahore 5
New Delhi 5
Padova 5
Totale 5.319
Salva come PNG Salva come JPEG
Nome #
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 451
Advances in systemic therapy for metastatic breast cancer: future perspectives 408
The predictive role of the immune system for response to therapy and survival in patients with solid tumors. 401
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 387
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 352
Bevacizumab in small cell lung cancer 341
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 334
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 303
Corticosteroid switch after progression on abiraterone acetate plus prednisone 285
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 283
Advances in systemic therapy for malignant mesothelioma: Future perspectives 270
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 263
Lenvatinib for the treatment of renal cell carcinoma 263
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 236
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 235
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 217
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 191
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 176
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 172
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses 158
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair 153
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy 149
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 146
Avelumab in gastric cancer 145
Mutant p53 as an antigen in cancer immunotherapy 133
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer 121
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 119
Cancer management during the COVID-19 world pandemic 112
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 107
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 100
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer 94
Cancer/testis antigens: from serology to mRNA cancer vaccine 93
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study 93
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors? 83
Current Trends in Liquid Biopsy Tracking Resistance in Molecular Breast Cancer-Targeted Therapies 78
P53 antibodies as a diagnostic marker for cancer: A meta-analysis 74
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer 66
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 64
The fibroblast growth factor receptors in breast cancer: From oncogenesis to better treatments 63
Totale 7.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 78 38 38
2021/2022448 31 42 43 37 10 38 26 14 53 61 17 76
2022/2023598 58 100 77 77 50 79 4 62 51 10 21 9
2023/2024530 13 67 57 45 33 43 103 84 2 26 31 26
2024/20251.278 13 123 186 95 97 118 68 56 156 141 104 121
2025/20262.154 239 150 149 287 235 206 305 83 209 291 0 0
Totale 7.719